Cracking the Patent Code: Natco’s Winning Formula

2 days ago 4

Natco Pharma, a leader in APIs and niche generics, faces growth challenges post-Revlimid exclusivity in FY26, with semaglutide offering long-term potential—but what's in store for the medium term?

View Entire Post

Read Entire Article